ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ZLAB Zai Lab Ltd

19.85
-0.08 (-0.40%)
最終更新日: 22:38:46
15分遅延
名称 銘柄コード 市場 種別
Zai Lab Ltd ZLAB NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.08 -0.40% 19.85 22:38:46
始値 安値 高値 終値 前日終値
19.84 19.83 20.01 19.93
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1705:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1620:30BWZai Lab Announces Participation in May and June Investor..
2024/5/1605:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1502:22EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1420:30BWZai Lab Announces Acceptance of Supplemental Biologics..
2024/5/1309:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
2024/5/0905:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0905:09EDGAR2Form 8-K - Current report
2024/5/0905:05BWZai Lab Announces First Quarter 2024 Financial Results and..
2024/4/1520:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
2024/4/1120:30BWZai Lab Statement on Executive Management Team’s Agreement..
2024/4/0220:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
2024/4/0120:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
2024/3/2722:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
2024/3/1408:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
2024/3/0706:01BWZai Lab to Present Final Overall Survival (OS) Data from..
2024/3/0621:30BWZai Lab Announces Participation in March Investor Conference
2024/3/0506:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2806:12EDGAR2Form 8-K - Current report
2024/2/2806:05BWZai Lab Announces Full-Year 2023 Financial Results and..
2024/2/0906:37EDGAR2Form 8-K - Current report
2024/1/2606:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
2024/1/1107:12BWZai Lab Announces The New England Journal of Medicine..
2024/1/0409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0405:50EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0405:47EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0405:42EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2306:29EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/12/1921:30BWZai Lab Announces Participation in January Investor..
2023/12/1907:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1322:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
2023/12/1313:10BWZai Lab Announces the First Listing of VYVGART®..
2023/11/1708:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0806:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:10EDGAR2Form 8-K - Current report
2023/11/0806:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
2023/11/0405:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0304:20EDGAR2Form 144 - Report of proposed sale of securities
2023/10/2620:30GLOBEZai Lab Announces Participation in November Investor..
2023/10/1820:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
2023/10/0406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1820:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
2023/9/0819:12EDGAR2Form 144 - Report of proposed sale of securities
2023/8/3020:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
2023/8/2920:38GLOBEZai Lab Announces Participation in September Investor..
2023/8/2205:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2205:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock